as on January 28, 2026 at 7:59 am IST
Day's Low
1.13%
Downside
52 Week's Low
52 Week's High
66.42%
Downside
0.38%
Upside
Check Repare Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Repare Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $- | NA | NA | 0.00% | |
| BUY | $47.7B | 100.62% | 1246.03 | 1.36% | |
| BUY | $122.3B | 113.14% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 53.64% | 18.28 | 32.13% |
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Repare Therapeutics Inc. Average target price of $3
Get share price movements and forecasts by analysts on Repare Therapeutics Inc.
What analysts predicted
11.67%UPSIDE
Target Price
$3
Current Price
$2.65
Analyzed by
13 Analysts
Target
$3.00
Repare Therapeutics Inc target price $3, a slight upside of 11.67% compared to current price of $2.65. According to 13 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 24 December
Wed, 06:19 PM
-Repare Therapeutics agrees to sell RP-3467 to Gilead for up to $30 million, boosting cash balance and shareholder value.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -30.04M → 3.25M (in $), with an average increase of 346.7% per quarter
Price Rise
![]()
In the last 3 months, RPTX stock has moved up by 48.9%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, -53.47M → 11.62M (in $), with an average increase of 10794.3% per quarter
Best in 1 Year
![]()
In the last 1 year, RPTX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 108.1%
| Organisation | Repare Therapeutics Inc |
| E-voting on shares | Click here to vote |
Repare Therapeutics Inc share price today is $2.65 as on at the close of the market. Repare Therapeutics Inc share today touched a day high of $2.65 and a low of $2.62.
Repare Therapeutics Inc share touched a 52 week high of $2.66 on and a 52 week low of $0.89 on . Repare Therapeutics Inc stock price today i.e. is closed at $2.65,which is 0.38% down from its 52 week high and 197.75% up from its 52 week low.
Indian investors can start investing in Repare Therapeutics Inc (RPTX) shares with as little as ₹90.662 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.62 in Repare Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Repare Therapeutics Inc share’s latest price of $2.65 as on January 28, 2026 at 2:29 am IST, you will get 3.7736 shares of Repare Therapeutics Inc. Learn more about
fractional shares .